RNS Number : 3365H
e-Therapeutics plc
12 March 2018

e-Therapeutics plc


("e-Therapeutics" or the "Company")


Notification of Full Year Results Date


Oxford, UK - 12 March 2018 - e-Therapeutics plc (AIM: ETX), a company using Network-Driven Drug Discovery (NDD) to create new and better drugs, will announce its full year results for the year ended 31 January 2018 on Tuesday, 27 March 2018.




For more information, please contact:


e-Therapeutics plc

Raymond Barlow, CEO

Steve Medlicott, Finance Director


Tel: +44 (0)1993 883 125 


Numis Securities Limited

Michael Meade / Freddie Barnfield (Corporate Finance)

James Black (Corporate Broking)


Tel: +44 (0) 207 260 1000


Instinctif Partners

Melanie Toyne Sewell / Alex Shaw / Deborah Bell

Tel: +44 (0) 207 457 2020




About e-Therapeutics plc


e-Therapeutics is an Oxford-based company with a unique and powerful computer-based drug discovery platform and a specialised approach to network biology. 


Its novel methodology and Discovery Engine allow the Company to discover new and better drugs in a more efficient and effective way.


For more information about the Company, please visit

This information is provided by RNS
The company news service from the London Stock Exchange